A detailed history of Journey Strategic Wealth LLC transactions in Pfizer Inc stock. As of the latest transaction made, Journey Strategic Wealth LLC holds 36,292 shares of PFE stock, worth $956,657. This represents 0.04% of its overall portfolio holdings.

Number of Shares
36,292
Previous 24,554 47.8%
Holding current value
$956,657
Previous $687,000 52.84%
% of portfolio
0.04%
Previous 0.03%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$27.7 - $31.39 $325,142 - $368,455
11,738 Added 47.8%
36,292 $1.05 Million
Q2 2024

Aug 14, 2024

BUY
$25.26 - $29.6 $78,356 - $91,819
3,102 Added 14.46%
24,554 $687,000
Q1 2024

May 13, 2024

BUY
$25.89 - $29.73 $356,324 - $409,173
13,763 Added 179.0%
21,452 $595,000
Q4 2023

Feb 09, 2024

SELL
$26.13 - $33.94 $226,939 - $294,768
-8,685 Reduced 53.04%
7,689 $221,000
Q3 2023

Nov 08, 2023

SELL
$32.09 - $37.51 $91,681 - $107,166
-2,857 Reduced 14.86%
16,374 $543,000
Q2 2023

Aug 14, 2023

SELL
$36.12 - $41.79 $294,992 - $341,298
-8,167 Reduced 29.81%
19,231 $705,000
Q1 2023

May 11, 2023

BUY
$39.39 - $51.28 $161,341 - $210,042
4,096 Added 17.58%
27,398 $1.12 Million
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $66,340 - $86,600
1,589 Added 7.32%
23,302 $1.19 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $62,883 - $76,764
1,437 Added 7.09%
21,713 $951,000
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $26,289 - $31,171
565 Added 2.87%
20,276 $1.06 Million
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $29,920 - $37,075
654 Added 3.43%
19,711 $1.02 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $787,435 - $1.17 Million
19,057 New
19,057 $1.13 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Journey Strategic Wealth LLC Portfolio

Follow Journey Strategic Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Journey Strategic Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Journey Strategic Wealth LLC with notifications on news.